Results 51 to 60 of about 356,569 (161)

Long-term outcome of pulmonary involvement in patients with coronavirus disease 2019: The role of high-resolution computed tomography and functional status – A prospective single-center observational study

Annals of Thoracic Medicine
BACKGROUND: Since its first outbreak, coronavirus disease 2019 (COVID-19) has led to a great deal of published literature highlighting the short-term determinants of morbidity and mortality.
Sadia Imtiaz, Enas M Batubara, Mohammed H Abuelgasim, Mahdi M Alabad, Lujain Mahmoud Alyousef, Nayef H Alqahtani, Alaa Y Sabbagh, Fawaz A Alharbi, Ahmed S Ibrahim   +8 more
doaj   +1 more source

Famotidine and Coronavirus Disease 2019 [PDF]

Gastroenterology, 2021
Daniel E. Freedberg, Timothy C. Wang, Julian A. Abrams   +2 more
openaire   +2 more sources

Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019

Critical Care Explorations, 2021
IMPORTANCE:. In bacterial sepsis, CD14 and its N-terminal fragment (soluble CD14 subtype, “Presepsin”) have been characterized as markers of innate immune responses and emerging evidence has linked both to coronavirus disease 2019 pathophysiology ...
F. Linzee Mabrey, MD, Eric D. Morrell, MD, Pavan K. Bhatraju, MD, MSc, Neha A. Sathe, MD, Sana S. Sakr, PhD, Sharon K. Sahi, BS, T. Eoin West, MD, MPH, Carmen Mikacenic, MD, Mark M. Wurfel, MD, PhD   +8 more
doaj   +1 more source

Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?

BMC Medicine, 2020
Background COVID-19, a disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), commonly presents as fever, cough, dyspnea, and myalgia or fatigue.
Violetta Opoka-Winiarska, Ewelina Grywalska, Jacek Roliński   +2 more
doaj   +1 more source

Coronavirus disease 2019: reassembly attack of coronavirus

International Journal of Environmental Health Research, 2020
There have been three major global outbreaks of acute respiratory disease caused by coronavirus in the last two decades. The ongoing Coronavirus Disease 2019 (COVID-19) first emerged in Wuhan, China, is the most dangerous, which spread to 163 countries and 6 continents and caused a major public health emergency worldwide.
Yang, Chenglei, Qiu, Xue, Fan, Haoran, Jiang, Mei, Lao, Xiaojie, Zeng, Yukeng, Zhang, Zhiming   +6 more
openaire   +2 more sources

COVID 19-Fighting an unseen enemy

APIK Journal of Internal Medicine, 2020
In December 2019, a previously unknown coronavirus, named SARS-CoV-2, was discovered in Wuhan, Hubei province of China. It was sequenced and isolated by January 2020.
Vasantha Kamath, Shreyashi Ganguly, B Nivea   +2 more
doaj   +1 more source

Effect of Smoking on the Progression and Severity of COVID-19 Infection among Adult Males in Sullia Taluk of Dakshina Kannada

Journal of Indian Association of Public Health Dentistry
Context Coronavirus disease 2019 (COVID-19) primarily targets pulmonary epithelial cells, causing viral pneumonia and acute respiratory distress syndrome. It progresses more severely in chronic obstructive pulmonary disease patients.
Christa Jose, Nusrath Fareed, P. K. Asmin, Hemanth Battur, Jaseela Praveena   +4 more
doaj   +1 more source

Proposed measures to be taken by ophthalmologists during the coronavirus disease 2019 pandemic: Experience from Chang Gung Memorial Hospital, Linkou, Taiwan

Taiwan Journal of Ophthalmology, 2020
PURPOSE: Although Taiwan was one of the first countries to develop coronavirus disease 2019 (COVID-19), with effective antiepidemic measures, Taiwan has effectively controlled the spread of the disease.
Jui-Yen Lin, Eugene Yu-Chuan Kang, Po-Han Yeh, Xiao Chun Ling, Hung-Chi Chen, Kuan-Jen Chen, Yih-Shiou Hwang, Chi-Chun Lai, Wei-Chi Wu   +8 more
doaj   +1 more source

Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients

Critical Care Explorations, 2020
Objectives:. Coronavirus disease 2019 patients admitted to the ICU have high mortality. The host response to coronavirus disease 2019 has only been partially elucidated, and prognostic biomarkers have not been identified. We performed targeted proteomics
Douglas D. Fraser, MD, PhD, Gediminas Cepinskas, DVM, PhD, Eric K. Patterson, PhD, Marat Slessarev, MD, MSc, Claudio Martin, MD, MSc, Mark Daley, PhD, Maitray A. Patel, BSc, Michael R. Miller, PhD, David B. O’Gorman, PhD, Sean E. Gill, PhD, Guillaume Pare, MD, MSc, Ioannis Prassas, PhD, Eleftherios Diamandis, MD, PhD, on behalf of the Lawson COVID19 Study Team, Robert Arntfield, Ian Ball, Gordon Barkwell, Tracey Bentall, Karen Bosma, Saoirse Cameron, Eileen Campbell, David Carter, Carolina Gillio-Meina, Robert Hegele, Natalya Odoardi, Ram Singh, Kelly Summers, Sue Tereschyn   +27 more
doaj   +1 more source

Treatment of coronavirus disease 2019

Current Opinion in HIV and AIDS, 2020
Purpose of review Coronavirus disease 2019 (COVID-19) is a highly contagious and potentially lethal pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). No specific antiviral treatment is currently available.
openaire   +2 more sources